Cancer Medicine

Article	Citations
Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer	153
Inequalities in survival and care across social determinants of health in a cohort of advanced lung cancer patients in Quebec (Canada): A high‐resolution population‐level analysis	100
The genomic landscape of teenage and young adult T‐cell acute lymphoblastic leukemia	95
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer, in	93
FDG uptake reflects an immune‐enriched subtype of thyroid cancer: Clinical implications of imaging‐based molecular characterization	89
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers	87
Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials	76
Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland	74
Predicting anxiety in cancer survivors presenting to primary care – A machine learning approach accounting for physical comorbidity	70
Inhibition of FGFR3 upregulates MHC‐I and PD‐L1 via TLR3/NF‐kB pathway in muscle‐invasive bladder cancer	61
Is tumor necrosis a clinical prognostic factor in hepato‐biliary‐pancreatic cancers? A systematic review and meta‐analysis	57
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial	56
Clinical value of endoscopic ultrasound sound speed in differential diagnosis of pancreatic solid lesion and prognosis of pancreatic cancer	55
Combination tumor‐treating fields treatment for patients with metastatic non‐small cell lung cancer: A cost‐effectiveness analysis	54
Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis	54
Comprehensive analysis indicated that NDE1 is a potential biomarker for pan‐cancer and promotes bladder cancer progression	52
MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma	52
Clinical characteristics, tumor‐infiltrating lymphocytes, and prognosis in HER2‐low breast cancer: A comparison study with HER2‐zero and HER2‐positive disease	49
Issue Information	48
Autologous menisci–cruciate ligament composite as a flap for soft tissue reconstruction following malignant bone tumor resection around the knee	47
CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation	47
It is not the time to abandon intraoperative frozen section in endometrioid adenocarcinoma: A large‐scale, multi‐center, and retrospective study	46
Characterization of the gene signature correlated with favorable response to chemoradiotherapy in rectal cancer: A hypothesis‐generating study	45
Cover Image	45
Insulin‐like growth factor binding protein‐2 and glucose‐regulated protein 78 kDa: Potential biomarkers affect prognosis in IDH‐wildtype glioblastoma patients	45

Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real‐world study	44
Issue Information	44
Radiation enteropathy‐related depression: A neglectable course of disease by gut bacterial dysbiosis	43
Immunoinfiltration Analysis of Mitochondrial Damage‐Related Genes in Lung Adenocarcinoma and Construction of a Classification and Prognostic Model Integrated With WGCNA and Machine Learning	42
The MIR181A2HG/miR‐5680/VCAN‐CD44 Axis Regulates Gastric Cancer Lymph Node Metastasis by Promoting M2 Macrophage Polarization	42
Pivotal role of myeloid‐derived suppressor cells in infection‐related tumor growth	42
A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features	41
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma	40
Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration	40
Macrophage Infiltration and ITGB2 Expression in ESCC: A Novel Correlation	40
Retraction	39
Retraction: lncRNA ABHD11‐AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2	38
Inequities in the Time to Colon Cancer Diagnosis Among Individuals With Severe Psychiatric Illness	38
Encapsulated papillary carcinoma of the breast: An institutional case series and literature review	38
A Novel Molecular Profile of Hormone‐Sensitive Prostate Cancer Defines High Risk Patients	37
Social Determinants of Health Predict Sleep–Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross‐Sectional Analysis	37
Transcriptomic Profiles for Elucidating Response of Bladder Intracavitary Hyperthermic Perfusion Chemotherapy in High‐Risk Nonmuscular Invasive Bladder Cancer	37
Development and validation of a novel nomogram predicting clinically significant prostate cancer in biopsy‐naive men based on multi‐institutional analysis	36
Perspectives surrounding fertility preservation and posthumous reproduction for adolescent and young adults with terminal cancer: Survey of allied health professionals	36
LncRNA BCLET variant confers bladder cancer susceptibility through alternative splicing of MSANTD2 exon 1	36
Worsened outcomes of newly diagnosed cancer in patients with recent emergency care visits: A retrospective cohort study of 3699 adults in a safety net health system	35
Exercise during chemotherapy: Friend or foe?	35
Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer	35
Clinician perceptions on barriers and facilitators to 1‐year surveillance colonoscopy completion in survivors of colorectal cancer	34
Conditional survival in breast cancer up to 10 years in the Nordic countries	34
RETRACTION: Long Noncoding RNA UFC1 is Activated by E2F1 and Exerts Oncogenic Properties by Functioning as a CeRNA of FOXP3	34
Skull defect increases the tumor treating fields strength without detrimental thermogenic effect: A computational simulating research	34
Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory phase II tr	33
CD11b/CD86 involved in the microenvironment of colorectal cancer by promoting Wnt signaling activation	33
The Optimal First‐Line Therapy for Extensive‐Stage Small‐Cell Lung Cancer Based on Liver Metastasis Status: A Network Meta‐Analysis and Systematic Review	33
Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes	32
Comparison of outcomes following lobectomy, segmentectomy, and wedge resection based on pathological subtyping in patients with pN0 invasive lung adenocarcinoma ≤1 cm	32
Current perspectives of cardio‐oncology: Epidemiology, adverse effects, pre‐treatment screening and prevention strategies	32
Causal associations between gastroesophageal reflux disease and lung cancer risk: A Mendelian randomization study	32
Cardiotoxicity screening of long‐term, breast cancer survivors—The CAROLE (Cardiac‐Related Oncologic Late Effects) Study	32
Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR‐370‐3p/SNAIL axis by inducing cell epithelial‐mesenchymal transition (EMT)	32
Impact of high neutrophil‐to‐lymphocyte ratio on survival in hospitalized cancer patients with COVID‐19	32
Traditional Chinese medicines and capecitabine‐based chemotherapy for colorectal cancer treatment: A meta‐analysis	32
NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability	32
Comparison of sampling methods for next generation sequencing for patients with lung cancer	31
Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin	31
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project	31
Deconvolution of bulk gene expression profiles reveals the association between immune cell polarization and the prognosis of hepatocellular carcinoma patients	30
Issue Information	30
Cigarette smoke condensate induces centrosome clustering in normal lung epithelial cells	29
Development of a nutritional screening and assessment indicator system for patients with esophageal cancer in China: Findings from the Delphi method	29
Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure	29
Reduced expression of alanyl aminopeptidase is a robust biomarker of non‐familial adenomatous polyposis and non‐hereditary nonpolyposis colorectal cancer syndrome early‐onset colorectal cancer	29
MDSC suppresses T cell antitumor immunity in CAC via GPNMB in a MyD88‐dependent manner	29
Cover Image	29

Kidney‐sparing surgery for distal high‐risk ureteral carcinoma: Clinical efficacy and preliminary experiences in 22 patients	28
Inhibition of lncRNA PCAT19 promotes breast cancer proliferation	28
Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum‐refractory/resistant ovarian cancer	28
Neoadjuvant androgen deprivation therapy combined with abiraterone acetate in patients with locally advanced or metastatic prostate cancer: When to perform radical prostatectomy?	28
KIAA1429 mediates epithelial mesenchymal transition in sorafenib‐resistant hepatocellular carcinoma through m6A methylation modification	28
Prediction value with a novel and accurate tissue‐based human papillomavirus detection method in low‐grade squamous intraepithelial lesions	28
Genetic ancestry, differential gene expression, and survival in pediatric B‐cell acute lymphoblastic leukemia	27
Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation	27
Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis	27
Clinical results of active surveillance for extra‐abdominal desmoid‐type fibromatosis	27
Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations	26
	26
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimens	26
Expression of PTGS2 along with genes regulating VEGF signalling pathway and association with high‐risk factors in locally advanced oral squamous cell carcinoma	26
Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma	26
Do breast cancer survivors with a recent history of clinical depression report worse experiences with care? A retrospective cohort study using SEER‐CAHPS data	26
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial	25
Impact of race‐specific screening guideline on the uptake of colorectal cancer screening among young African Americans	25
Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer	25
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia	25
Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer	25
HTLV‐1 Tax‐specific memory cytotoxic T lymphocytes in long‐term survivors of aggressive‐type adult T‐cell leukemia/lymphoma	25
Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable‐risk prostate cancer	25
Risk of cardiovascular disease in cancer survivors: A cohort study of 446,384 New Zealand primary care patients	25
Nicotinamide N‐methyltransferase is related to MELF pattern invasion in endometrioid carcinoma	25
A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study	25
Characterization of RNA modifications in gastric cancer to identify prognosis‐relevant gene signatures	24
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index	24
Establishing a robust radioligand therapy program: A practical approach for North American centers	24
Association of blood cell‐based inflammatory markers with gut microbiota and cancer incidence in the Rotterdam study	24
Association of area‐level mortgage denial and guideline‐concordant non‐small‐cell lung cancer care and outcomes in the United States	24
Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic	24
Fertility counselling and fertility preservation among early onset female cancer patients—A Finnish register‐based study	24
Healthcare costs of cancer among children, adolescents, and young adults: A scoping review	24
Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population	23
Enrichment of Cancer‐Associated Fibroblasts, Macrophages, and Up‐Regulated TNF‐α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal Metastasis	23
Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising‐VTE/NEJ037 Study	23
The Association Between Body Composition, Overall Survival, Treatment Decisions, and Patient‐Reported Outcomes in Metastatic Non‐Small‐Cell Lung Cancer	23
Molecular Mechanisms of Synergistic Effect of PRIMA‐1met and Oxaliplatin in Colorectal Cancer With Different p53 Status	23
Clinicopathological comparison between PTCL‐TBX21 and PTCL‐GATA3 in Japanese patients	23
Exploring Multiplex Immunohistochemistry (mIHC) Techniques and Histopathology Image Analysis: Current Practice and Potential for Clinical Incorporation	23
Patient and Caregiver Perceptions of Caregiving Contributions During Cancer Clinical Trials: A Mixed‐Methods Study	23
Drivers of Palliative Care and Hospice Use Among Patients With Advanced Lung Cancer	23
Differentiating Pulmonary Nodule Malignancy Using Exhaled Volatile Organic Compounds: A Prospective Observational Study	23
Neurocognitive and psychosocial outcomes in survivors of childhood leukemia with Down syndrome	23
Repurposing of Metformin to Improve Survival Outcomes in Patients With Upper Tract Urothelial Carcinoma	23
	23
The Effect of Expressive Writing on the Experiences of Head and Neck Cancer Patients Undergoing Radiotherapy: A Randomized Controlled Trial	23
Identification of novel pQTL‐SNPs associated with lung adenocarcinoma risk: A multi‐stage study	22
Potential therapeutic effects of apigenin for colorectal adenocarcinoma: A systematic review and meta‐analysis	22
Radiomic prediction for durable response to high‐dose methotrexate‐based chemotherapy in primary central nervous system lymphoma	22
Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer	22
Mammography Among Women Residing in Urban Versus Rural Utah: Breast Cancer Survival	22
Immune‐dysregulation harnessing in myeloid neoplasms	22
Real‐World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)‐Mutant Metastatic Non‐Small Cell Lung Cancer, From a US‐Based Clinico‐Genomic Database	21
The impact of symptom screening on survival among patients with cancer across varying levels of pre‐diagnosis psychiatric care	21
Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study	21
Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer	21
The pathophysiology of cancer‐mediated cardiac cachexia and novel treatment strategies: A narrative review	21
Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of MYCN	21
Tools to assess employment readiness for colorectal cancer survivors: A scoping review	21
The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment	21
Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G	21
	21
Survival of cancer survivors with a new pancreatic cancer diagnosis	21
Real‐world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system	21
Comparison of the clinical efficacies of two L‐asparaginase‐based chemotherapy regimens for newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma	21
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion	21
Real‐world analysis of the prognostic value of EGFR mutation detection in plasma ctDNA from patients with advanced non‐small cell lung cancer	21
Development and validation of a cost‐effective virtual reality educational tool to reduce anxiety and improve set‐up accuracy in radiotherapy patients	20
Issue Information	20
Cover Image	20
The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies	20
Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study	20
The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida	20
The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study	20
Application of computer‐aided detection for NCCN‐based follow‐up recommendation in subsolid nodules: Effect on inter‐observer agreement	20
Issue Information	20
Issue Information	20
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment	20

An international multicenter study comparing COVID‐19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab	20
Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine‐induced toxicity in an Asian population	20
	20
Cancer and the family: Variations by sex and race/ethnicity	20
Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma	20
IMMUNOREACT 0: Biopsy‐based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer—A systematic review and meta‐analysis	20
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study	20
Prevalence of frailty and prediction of mortality in Chinese cancer patients using a frailty index‐based clinical algorithm—A multicentre study	19
Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer	19
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma	19
Experiences of caregivers of children with cancer in Malawi: A qualitative study	19
BMI changes and the risk of lung cancer in male never‐smokers: A prospective cohort study	19
Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy	19
Association between F‐box‐only protein 43 overexpression and hepatocellular carcinoma pathogenesis and prognosis	19
In‐depth proteomics reveals the characteristic developmental profiles of early lung adenocarcinoma with epidermal growth factor receptor mutation	19
Trajectories and risk factors for anxiety and depression in children and adolescents with cancer: A 1‐year follow‐up	19
Severe anaphylaxis caused by intravenous anti‐cancer drugs	19
PD‐L1 expression is associated with the spontaneous regression of patients with methotrexate‐associated lymphoproliferative disorders	19
Cancer screening in people living with HIV	19
Remote assessment of cognitive dysfunction in hematologic malignancies using web‐based neuropsychological testing	19
Virtual follow‐up care among breast and prostate cancer patients during and beyond the COVID‐19 pandemic: Association with distress	19
Mixed reality navigation training system for liver surgery based on a high‐definition human cross‐sectional anatomy data set	18
Impact of the model of long‐term follow‐up care on adherence to guideline‐recommended surveillance among survivors of adolescent and young adult cancers	18
	18
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma	18
Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor‐node‐metastasis classification of colorectal cancer and the 9th edition of the Japa	18
Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort	18
Impact of body mass index on perioperative and oncological outcomes in elderly patients undergoing minimally invasive McKeown esophagectomy for esophageal squamous cell carcinoma	18
National variation in the delivery of radiation oncology procedures in the non‐facility‐based setting	18
Safety and efficacy of GEMOX plus donafenib and tislelizumab as first‐line therapy for advanced epithelial malignant biliary tract cancer	18
Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma	18
Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017	18
Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non‐small cell lung cancer	18
Clinical significance and outcomes of bilateral and unilateral recurrent laryngeal nerve lymph node dissection in esophageal squamous cell carcinoma: A large‐scale retrospective cohort study	18
SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway	18
	18
Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus	18
Cover Image	18
Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis	18
Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes	18
Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclines	17
Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994–2018)	17
Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity	17
Long‐term survivors with desmoplastic small round cell tumor (DSRCT): Results from a retrospective single‐institution case series analysis	17
Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A Nation	17
Issue Information	17
Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients	17
Combined plasma C‐reactive protein, interleukin 6 and YKL‐40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer	17
Low‐energy amplitude‐modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma	17
Clinical efficacy and safety of adjuvant EGFR‐TKIs for resected stage IB lung adenocarcinoma: A real‐world study based on propensity score matching	17
Pre‐diagnosis lipid levels and mortality after obesity‐related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort	17
Assessing patterns in cancer screening use by race and ethnicity during the coronavirus pandemic using electronic health record data	17
Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study	17
Lung cancer incidences after liver transplantation: A systematic review and meta‐analysis	17
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II	17
Administration of a glypican‐3 peptide increases the infiltration and cytotoxicity of CD8+ T cells against testicular yolk sac tumor, associated with enhancing the intratumoral <	17
Region of origin and cervical cancer stage in multiethnic Hispanic/Latinx patients living in the United States	17
Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study	17
Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma	17
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of th	17
Breast cancer in Zimbabwe: patterns of care and correlates of adherence in a national referral hospital radiotherapy center cohort from 2014 to 2018	17
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet‐Uro 19BEYOND study	17
Ultrasound‐guided hookwire localization of non palpable cervical lymphadenopathy: A case–control study of operative time	17
Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement—A retrospective study	17
Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer	17
The impact of the COVID‐19 pandemic on perioperative chemotherapy for breast cancer	17
Issue Information	16
The heterogeneous impact of targeted therapy on the prognosis of stage III/IV colorectal cancer patients with different subtypes of TP53 mutations	16
Health‐related quality of life at 3 months following head and neck cancer treatment is a key predictor of longer‐term outcome and of benefit from using the patient concerns inventory	16
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in patients with triple‐negative breast cancer: A systematic review and meta‐analysis	16
Construction and validation of a novel aging‐related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer	16
eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients	16
Immunotherapy combined with antiangiogenic therapy as third‐ or further‐line therapy for stage IV non‐small cell lung cancer patients with ECOG performance status 2: A retrospect	16
Accuracy of curability expectations in patients with gastrointestinal cancers	16
A single‐center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan	16
Mutational pattern off homologous recombination repair (HRR)‐related genes in upper tract urothelial carcinoma	16
βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells	16
Withdrawal Notice	16
Changes in parents' psychotropic medication use following child's cancer diagnosis: A fixed‐effects register‐study in Finland	16
A second‐generation CD38‐CAR‐T cell for the treatment of multiple myeloma	16
Psychological states and needs among post‐allogeneic hematopoietic stem cell transplantation survivors	16
The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages	16
Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival	16
Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma	16
Perioperative opioids and survival outcomes in resectable head and neck cancer: A systematic review	16
Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors	16
Comorbidity, lifestyle factors, and sexual satisfaction among Chinese cancer survivors	16
Temporal increase in the incidence of anal squamous cell carcinoma in Kentucky and factors associated with adverse outcomes	16
Patterns and predictors of cancer‐specific patient health portal usage among patients with cancer: results from the UWCCC Survivorship Program	16
Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer	15
Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein‐1 inhibitors: A promising treatment approach for high‐burden hepatocellular carcinoma	15
Impact of obesity on sentinel lymph node biopsy outcomes and survival in breast cancer patients: A single‐center retrospective study	15
PD‐1 blockade enhances the effect of targeted chemotherapy on locally advanced pMMR/MSS colorectal cancer	15
Preclinical evidence for the use of anti‐Trop‐2 antibody‐drug conjugate Sacituzumab govitecan in cerebral metastasized castration‐resistant prostate cancer	15
Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real‐world analysis	15